Malaria, Falciparum Clinical Trial
Official title:
Intermittent Preventive Treatment in Schools: a Randomised Controlled Trial of the Impact of IPT on Malaria, Anaemia and Education Amongst Schoolchildren in Western Kenya
This study seeks to establish whether intermittent preventive treatment (IPT) can reduce malaria among school-going children and its consequent impact on school performance.
Although the risk of malaria is greatest in early childhood, significant numbers of
schoolchildren remain at risk from malaria-specific morbidity and mortality. Each year
between 20-50% of schoolchildren, aged 10-14 years, living in malaria-endemic areas will
experience a clinical attack of malaria (Clarke et al., 2004). Malaria accounts for 3-8% of
all-cause absenteeism from school, and up to 50% of preventable absenteeism (Brooker et al.,
2000). In addition, asymptomatic parasitaemia contributes to anaemia, reducing concentration
and learning in the classroom (Holding & Snow, 2001). Intermittent preventive treatment
(IPT) delivered through schools is a simple intervention, which can be readily integrated
into broader school health programmes. This study seeks to examine whether IPT can reduce
malaria and anaemia amongst school-going children, and its consequent impact on school
performance, in order to assess its suitability for inclusion as a standard intervention in
school health programmes.
The efficacy of IPT is being evaluated in schoolchildren with a high-level of acquired
immunity and ability to limit parasite growth, in whom most infections are asymptomatic and
may go untreated.
The intervention: Intermittent preventive treatment of malaria administered each school term
with the purpose to reduce asymptomatic parasitaemia and prevent clinical attacks, thereby
reducing anaemia and school absenteeism, with consequences for improved attendance and
concentration in class.
Schools are randomly allocated to one of two arms:
- Intervention schools: IPT given three times a year (once per term) + mass treatment
with anthelminthics
- Control schools: mass treatment with anthelminthics only
Mass treatment with anthelminthics is carried out in all study schools twice annually in
accordance with national policy.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02329301 -
Mass Drug Administration With Dihydroartemisinin + Piperaquine for Reducing Malaria in Southern Zambia
|
N/A | |
Recruiting |
NCT01944189 -
Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics and Population Pharmacokinetics
|
Phase 4 | |
Completed |
NCT01325974 -
Time to Become Negative of Three Rapid Diagnostic Tests for Malaria
|
N/A | |
Terminated |
NCT01442168 -
Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria
|
Phase 1/Phase 2 | |
Terminated |
NCT00374205 -
Randomized Trial on Effectiveness of ACTs in Ghana
|
Phase 4 | |
Completed |
NCT00375128 -
Sporozoite Challenge of Polyprotein Vaccinees
|
Phase 1/Phase 2 | |
Completed |
NCT04609098 -
Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)
|
Phase 2 | |
Completed |
NCT02851108 -
Methylene Blue Against Falciparum Malaria in Burkina Faso
|
Phase 2 | |
Terminated |
NCT02281344 -
MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants
|
Phase 1 | |
Completed |
NCT02434952 -
Safety and Tolerability of Low Dose Primaquine
|
Phase 4 | |
Completed |
NCT01213966 -
Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection
|
Phase 2 | |
Completed |
NCT00479206 -
Artemisinin Resistance in Cambodia
|
N/A | |
Completed |
NCT00126906 -
Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi
|
N/A | |
Completed |
NCT01019408 -
Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in Pakistan
|
Phase 4 | |
Completed |
NCT00529867 -
Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria
|
Phase 4 | |
Completed |
NCT00137553 -
The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children
|
Phase 4 | |
Completed |
NCT02637128 -
In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria
|
Phase 4 | |
Completed |
NCT01222962 -
Food Interaction Study on the Pharmacokinetics of Eurartesimâ„¢ (DHA and PQP)in Healthy Male Adult Volunteers
|
Phase 1 | |
Unknown status |
NCT00152204 -
The Community Effectiveness of IPTi in Southern Tanzania
|
Phase 3 | |
Terminated |
NCT00084240 -
Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia
|
Phase 2/Phase 3 |